NeoGenomics quarterly revenue rises 11.4% to $209.3 million
NeoGenomics' revenue growth is holding steady. Results for the quarter ended September 30, 2026, from the earnings release filed with the SEC on Oct 28, 2026.
17.91▼ −0.42%
Latest · 2026-10-29
NeoGenomics' revenue growth is holding steady. Results for the quarter ended September 30, 2026, from the earnings release filed with the SEC on Oct 28, 2026.
2026-10-29